KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crocs (CROX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Crocs (CROX) over the last 17 years, with Q4 2025 value amounting to $130.4 million.

  • Crocs' Cash & Equivalents fell 2777.57% to $130.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $130.4 million, marking a year-over-year decrease of 2777.57%. This contributed to the annual value of $130.4 million for FY2025, which is 2777.57% down from last year.
  • Per Crocs' latest filing, its Cash & Equivalents stood at $130.4 million for Q4 2025, which was down 2777.57% from $154.0 million recorded in Q3 2025.
  • Crocs' Cash & Equivalents' 5-year high stood at $436.6 million during Q3 2021, with a 5-year trough of $125.7 million in Q1 2023.
  • In the last 5 years, Crocs' Cash & Equivalents had a median value of $169.9 million in 2022 and averaged $185.5 million.
  • Per our database at Business Quant, Crocs' Cash & Equivalents soared by 25334.57% in 2021 and then plummeted by 6725.36% in 2022.
  • Quarter analysis of 5 years shows Crocs' Cash & Equivalents stood at $213.2 million in 2021, then fell by 10.12% to $191.6 million in 2022, then dropped by 22.1% to $149.3 million in 2023, then grew by 20.9% to $180.5 million in 2024, then fell by 27.78% to $130.4 million in 2025.
  • Its Cash & Equivalents was $130.4 million in Q4 2025, compared to $154.0 million in Q3 2025 and $200.6 million in Q2 2025.